Irena Keber

1.7k total citations
59 papers, 1.3k citations indexed

About

Irena Keber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Irena Keber has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Irena Keber's work include Heart Failure Treatment and Management (15 papers), Lipoproteins and Cardiovascular Health (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Irena Keber is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Lipoproteins and Cardiovascular Health (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (8 papers). Irena Keber collaborates with scholars based in Slovenia, Sweden and United Kingdom. Irena Keber's co-authors include Miran Šebeštjen, Mitja Lainščak, Barbara Salobir, D. Keber, Mišo Šabović, Borut Jug, Stefan D. Anker, Nina Vene, Mojca Stegnar and Wolfgang Köenig and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, American Journal of Obstetrics and Gynecology and The American Journal of Cardiology.

In The Last Decade

Irena Keber

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irena Keber Slovenia 21 692 317 228 159 152 59 1.3k
Bruce M. Psaty United States 14 921 1.3× 328 1.0× 195 0.9× 184 1.2× 152 1.0× 19 1.7k
Gerry Ligtenberg Netherlands 22 1.1k 1.6× 277 0.9× 447 2.0× 135 0.8× 98 0.6× 35 2.4k
Larry A. Weinrauch United States 23 676 1.0× 445 1.4× 426 1.9× 115 0.7× 126 0.8× 93 1.8k
Giovanni B. Ambrosio Italy 20 762 1.1× 225 0.7× 221 1.0× 102 0.6× 156 1.0× 36 1.3k
Alberto Mazza Italy 24 597 0.9× 404 1.3× 361 1.6× 174 1.1× 142 0.9× 93 1.6k
Ji G. Wang Belgium 6 1.6k 2.4× 643 2.0× 242 1.1× 95 0.6× 71 0.5× 9 1.9k
J. C. M. Witteman Netherlands 12 568 0.8× 324 1.0× 568 2.5× 82 0.5× 174 1.1× 17 1.6k
Diederick E. Grobbee Netherlands 15 628 0.9× 278 0.9× 268 1.2× 59 0.4× 81 0.5× 17 1.5k
Ingrid Mattiasson Sweden 24 463 0.7× 398 1.3× 351 1.5× 207 1.3× 204 1.3× 77 1.7k
Kei Tsumura Japan 18 737 1.1× 310 1.0× 155 0.7× 241 1.5× 211 1.4× 45 1.6k

Countries citing papers authored by Irena Keber

Since Specialization
Citations

This map shows the geographic impact of Irena Keber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Keber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Keber more than expected).

Fields of papers citing papers by Irena Keber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Keber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Keber. The network helps show where Irena Keber may publish in the future.

Co-authorship network of co-authors of Irena Keber

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Keber. A scholar is included among the top collaborators of Irena Keber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Keber. Irena Keber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jug, Borut, et al.. (2013). Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction. Heart and Vessels. 29(3). 313–319. 14 indexed citations
2.
Vene, Nina, Barbara Salobir, Miran Šebeštjen, et al.. (2009). Prognostic impact of haemostatic derangements in chronic heart failure. Thrombosis and Haemostasis. 102(8). 314–320. 13 indexed citations
3.
Jug, Borut, Miran Šebeštjen, Mišo Šabović, Maja Pohar Perme, & Irena Keber. (2009). Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure. Wiener klinische Wochenschrift. 121(21-22). 700–706. 9 indexed citations
4.
Jensterle, Mojca, Miran Šebeštjen, Andrej Janež, et al.. (2008). Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome. European Journal of Endocrinology. 159(4). 399–406. 59 indexed citations
5.
Lainščak, Mitja, John G.F. Cleland, Mattie Lenzen, et al.. (2007). Recall of Lifestyle Advice in Patients Recently Hospitalised with Heart Failure: A EuroHeart Failure Survey Analysis. European Journal of Heart Failure. 9(11). 1095–1103. 49 indexed citations
6.
Lainščak, Mitja, John G.F. Cleland, Mattie Lenzen, et al.. (2007). Nonpharmacologic Measures and Drug Compliance in Patients with Heart Failure: Data from the EuroHeart Failure Survey. The American Journal of Cardiology. 99(6). S31–S37. 28 indexed citations
7.
8.
9.
Jug, Borut, et al.. (2006). Clopidogrel Is Associated With a Lesser Increase in NT-proBNP When Compared to Aspirin in Patients With Ischemic Heart Failure. Journal of Cardiac Failure. 12(6). 446–451. 9 indexed citations
10.
Šebeštjen, Miran, et al.. (2006). The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Menopause The Journal of The North American Menopause Society. 13(4). 643–650. 68 indexed citations
11.
Lainščak, Mitja & Irena Keber. (2006). Heart failure clinic in a community hospital improves outcome in heart failure patients. Swiss Medical Weekly. 136(1718). 274–280. 9 indexed citations
12.
Lainščak, Mitja & Irena Keber. (2005). Patients' Knowledge and Beta Blocker Treatment Improve Prognosis of Patients from a Heart Failure Clinic. European Journal of Heart Failure. 8(2). 187–190. 14 indexed citations
13.
Lainščak, Mitja, et al.. (2003). The management of patients with heart failure in a Slovenian community hospital: What has changed between 1997 and 2000?. Wiener klinische Wochenschrift. 115(10). 334–339. 9 indexed citations
14.
Keber, Irena, et al.. (2003). Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause. American Journal of Obstetrics and Gynecology. 188(5). 1291–1296. 11 indexed citations
15.
Keber, Irena, et al.. (2003). Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. Atherosclerosis. 168(1). 123–129. 59 indexed citations
16.
Šebeštjen, Miran, et al.. (2002). Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia. Journal of Internal Medicine. 251(1). 77–85. 22 indexed citations
17.
Keber, Irena, et al.. (2001). Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. Journal of Internal Medicine. 250(6). 508–515. 37 indexed citations
18.
Škof, Erik, et al.. (2001). Secondary Prevention in Patients Several Years after Myocardial Infarction: Comparison of an Outpatient and an Inpatient Rehabilitation Programme. European Journal of Cardiovascular Prevention & Rehabilitation. 8(3). 119–126. 3 indexed citations
19.
Petrovič, Daniel, et al.. (2001). Joint effect of G1691A factor V point mutation and factor VII Arg/Gln353 gene polymorphism on the risk of premature coronary artery disease. Annales de Génétique. 44(1). 33–36. 7 indexed citations
20.
Keber, Irena & D. Keber. (1992). Increased Plasminogen Activator Inhibitor Activity in Survivors of Myocardial Infarction Is Associated with Metabolic Risk Factors of Atherosclerosis. Pathophysiology of Haemostasis and Thrombosis. 22(4). 187–194. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Gerry Ligtenberg Breakdown of academic impact, for papers by Larry A. Weinrauch Breakdown of academic impact, for papers by Giovanni B. Ambrosio Breakdown of academic impact, for papers by Alberto Mazza Breakdown of academic impact, for papers by Ji G. Wang Breakdown of academic impact, for papers by J. C. M. Witteman Breakdown of academic impact, for papers by Diederick E. Grobbee Breakdown of academic impact, for papers by Ingrid Mattiasson Breakdown of academic impact, for papers by Kei Tsumura
Rankless by CCL
2026